Breast Cancer Trials
Breast Cancer Trials is an Australian charitable clinical trials research organization founded in 1978 that coordinates breast cancer treatment and prevention trials across 119 institutions in Australia and New Zealand, supported by a 1,068-researcher network, a biobank, and community donations.
- Company typePrivate
- Founded1978
- HeadquartersNewcastle, Australia
- Headcount11–50
- GTM typeB2B and B2C
- OfferingServices
What Breast Cancer Trials does
Breast Cancer Trials (legal entity ANZ Breast Cancer Trials Group Limited) is an Australian registered charity founded in 1978 and headquartered in Newcastle, NSW. It is the largest independent oncology clinical trials research group in Australia and New Zealand, running a coordinated multi-centre clinical trials program for breast cancer treatment, prevention, and cure. The organization coordinates approximately 95 clinical trials across recruitment, follow-up, analysis, and publication, engaging 1,068 researchers across 119 institutions in Australia and New Zealand plus 68 international sites, and collaborates with 21 international clinical trial groups including BIG, IBCSG, GBG, SOLTI, and TRIO. Core infrastructure includes the BCT Biobank in Newcastle holding thousands of specimens linked to clinical outcome data, a Remote Telehealth Pre-Screening Process to broaden rural and remote patient access, and a Clinical Fellowship Program supporting four new research clinicians annually.
The organization is funded through a diversified donor and fundraising model rather than commercial pricing. Revenue streams include individual one-time and monthly donations (with donations of $2+ AUD tax-deductible under DGR status), gifts in wills, workplace giving, corporate partnerships, merchandise such as the Australian Women's Health Diary, and a portfolio of national community fundraising events including the Pink Bloom Party, Big Bold Walk, Big Bold Swim, Get Active, and the long-running Tee Off golf initiative. It serves approximately 38,000 supporters and has supported 17,910+ clinical trial participants since inception, contributing to 1,361+ peer-reviewed scientific publications and practice-changing studies such as TAILORx, SOFT & TEXT, OlympiA, HERA, and BIG 1-98. Governance is provided by a Board of Directors under a not-for-profit structure, with no parent company and ACNC charity registration.
Breast Cancer Trials firmographics
Firmographics- Name
- Breast Cancer Trials
- Legal name
- ANZ Breast Cancer Trials Group Limited
- Website
- https://breastcancertrials.org.au
- Company type
- Private
- Founded year
- 1978
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Breast Cancer Trials is an Australian charitable clinical trials research organization founded in 1978 that coordinates breast cancer treatment and prevention trials across 119 institutions in Australia and New Zealand, supported by a 1,068-researcher network, a biobank, and community donations.
- Ownership category
- akta.pro rank
Breast Cancer Trials industry classification
Industry- Product category
- Oncology Clinical Trials Research
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Site Operations & Study Coordination (HLAGACAE)
- akta.pro secondary industries
- Gynecologic Oncology & Women’s Cancer Centers (HLAFAJAK), Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials) (HLAAANAI)
Keywords
Where Breast Cancer Trials is headquartered
LocationHeadquarters
- HQ city
- Newcastle
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Breast Cancer Trials business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Others
Revenue model
- Individual Donations: One-time and monthly donations from individuals, with tax-deductible status for donations of $2 or more in Australia.
- Fundraising Events: Revenue generated from events including Pink Bloom Party, Big Bold Walk, Big Bold Swim, Get Active sporting events, Tee Off golf events, and community fundraising activities.
- Gifts in Wills: Legacy giving program where supporters leave a gift in their Will to ensure ongoing support beyond their lifetime.
- Merchandise Sales: Sale of merchandise including the Australian Women's Health Diary and branded items to raise funds for research.
- Corporate Partnerships: Corporate donations and sponsorship arrangements with businesses supporting the breast cancer trials research program.
- Workplace Giving: Employee giving program allowing workers to make regular pre-tax donations through their employer's payroll system.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | One-time donation amounts: $30, $32, $55, $75, $85, $100, $250 |
| Subscription | Monthly | Monthly giving program with flexible contribution amounts |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
Breast Cancer Trials product offering
Product offeringCore offering
Breast Cancer Trials designs, coordinates, and conducts a multi-centre national and international clinical trials research program for breast cancer treatment, prevention, and cure, encompassing approximately 95 clinical trials across recruitment, follow-up, analysis, and publication stages. The program is delivered through 119 institutions in Australia and New Zealand and 68 international sites, supported by translational research via the BCT Biobank, a Remote Telehealth Pre-Screening service for rural and regional patients, a Clinical Fellowship Program for emerging researchers, and patient-facing decision-support tools (iPrevent and the Neoadjuvant Patient Decision Aid).
Product overview
Breast Cancer Trials operates as a clinical trials research organization conducting a coordinated multi-centre national and international clinical trials program for breast cancer treatment, prevention, and cure. The core offering is the Clinical Trials Research Program encompassing approximately 95 clinical trials, supported by services including the Remote Telehealth Pre-Screening Process for broader patient access, a Translational Research/Biobank for specimen analysis, and a Clinical Fellowship Program for researcher development. The organization also runs a fundraising platform including events (Pink Bloom Party, Big Bold Walk, Big Bold Swim, Tee Off), merchandise (Australian Women's Health Diary), and provides researcher tools including a member portal and publications database. Patient-facing digital tools include iPrevent for risk assessment and a Neoadjuvant Patient Decision Aid. The organization collaborates with 119 institutions in Australia and New Zealand and 21 international clinical trial groups.
Differentiator
Problem solved
Functional benefit
Products and services
- Clinical Trials Research Program Coordinated multi-centre national and international breast cancer clinical trials research program encompassing approximately 95 trials across recruitment, follow-up, analysis and publication, delivered through 119 ANZ institutions and 68 international sites. Includes currently recruiting trials such as OLIO, PROSPECTIVE, and ROSALIE.
- Remote Telehealth Pre-Screening Process Remote telehealth service that enables rural, regional and remote patients to complete pre-screening for molecularly targeted breast cancer clinical trials in their local community, including blood test kits and pathology laboratory liaison for tissue samples.
- Translational Research / BCT Biobank Biobank resource located in Newcastle that holds thousands of specimens from Breast Cancer Trials clinical trials, linked to detailed clinical outcome data, supporting local researchers in analyses that influence the development of new BCT clinical research. Funded by BCRF grants since 2010.
- Clinical Fellowship Program Program supporting the next generation of breast cancer researchers through financial assistance for junior research clinicians, with four Clinical Fellows supported annually.
- Fundraising Events Platform National fundraising program encompassing Pink Bloom Party (October), Big Bold Walk (June), Big Bold Swim (February), Get Active sporting events, Tee Off golf initiative (running since 1996 and raising over $4 million), Race For A Cure, and community fundraising activities.
- Australian Women's Health Diary Annual health diary product sold by Breast Cancer Trials to raise funds for breast cancer clinical trials research, targeting women who want to make a difference to their own lives and others.
Quantifiable outcome
- 17,910+ trial participants have contributed to clinical trials research since 1978
- +3 more outcomes
Companies that use Breast Cancer Trials
Customer profileNamed customers1 record
Segments5 records
Ideal customer profiles3 records
Breast Cancer Trials technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Breast Cancer Trials partnerships and signals
Strategic signalPartnerships
13 partnerships are on record, tiered core and major.
- Clinical Oncological Society of Australia (COSA)coreBCT is a sustaining member of COSA, the peak national body for health professionals working in cancer control in Australia.
- Breast International Group (BIG)coreInternational collaboration ensuring women and specialists in Australia and New Zealand get early access to new, promising treatments and placing BCT at the forefront of research progress.
- International Breast Cancer Study Group (IBCSG)coreCollaboration with IBCSG (Switzerland and USA) on international clinical trials for breast cancer treatment and prevention.
- German Breast Group (GBG)coreCollaboration on international clinical trials with the German Breast Group.
- Alliance Foundation Trials (USA)majorInternational clinical trial collaboration with Alliance Foundation Trials based in the USA.
- Austrian Breast & Colorectal Cancer Study Group (ABCSG)majorInternational collaboration with ABCSG on breast cancer clinical trials.
- Canadian Cancer Trials Group (CCTG)majorInternational collaboration with Canadian Cancer Trials Group.
- Cancer Trials Ireland (CTI)majorInternational collaboration with Cancer Trials Ireland.
- SOLTI (Spain)majorInternational clinical trial collaboration with SOLTI based in Spain.
- Taiwan Breast Cancer Consortium (TBCC)majorInternational collaboration with Taiwan Breast Cancer Consortium.
- Translational Research in Oncology (TRIO)majorInternational collaboration with TRIO (France and Canada) on translational research in oncology.
- Australian New Zealand Clinical Trials RegistrymajorBCT clinical trials are registered on the ANZCTR, enabling patients and researchers to access information about breast cancer clinical trials available across Australia and New Zealand.
- 119 Australian and New Zealand InstitutionscoreNetwork of hospitals and cancer treatment centres across all Australian states/territories and New Zealand participating in BCT clinical trials research program, coordinated through BCT's head office in Newcastle.
Scale indicators10 records
Recent moves6 records
Expansion highlights5 records
Breast Cancer Trials competitors and assessment
Company assessmentBroad incumbents
- Susan G. Komen: Largest US-based breast cancer charity funding research, community health and advocacy globally. Comparable as a major breast cancer non-profit with similar fundraising and research funding model, but at much larger scale.
- Cancer Research UK: World's largest cancer research charity funding research across all cancer types. Comparable as a major cancer research non-profit with similar mission and fundraising model, though covering all cancers rather than breast alone.
- Cancer Council Australia: Largest Australian cancer charity umbrella organization funding research, advocacy and patient support across all cancer types. Comparable as a major Australian cancer non-profit competing for similar donor funding, but with broader scope.
Direct peers
- International Breast Cancer Study Group (IBCSG): International cooperative group based in Switzerland conducting breast cancer clinical trials. Direct peer as a clinical trials research organization with similar operational model and ongoing partnership with BCT.
- Alliance for Clinical Trials in Oncology: US-based clinical trials cooperative group and BCT collaboration partner. Comparable as an oncology-focused multi-center trial coordinating organization with academic medical center network.
- Breast International Group (BIG): International non-profit network coordinating breast cancer clinical trials globally. BCT is a member of BIG and they collaborate closely; BIG is the umbrella organization with similar trial-coordination mission across multiple countries.
- ECOG-ACRIN Cancer Research Group: Major US-based clinical trials cooperative group conducting cancer treatment trials. Comparable structure as a large multi-institutional oncology trials network with similar coordination and protocol development functions.
- National Breast Cancer Foundation (Australia): Australia's other major breast cancer-focused non-profit, funding research and clinical trials. Directly comparable as a domestic breast cancer charity with overlapping donor base, though NBCF is more research-grant oriented rather than trial-coordinating.
- NRG Oncology: US-based cooperative group conducting oncology clinical trials across multiple cancer types including breast. Comparable as a multi-center clinical trials research organization with academic institution network and NCI funding.
Regional players
- McGrath Foundation: Australian breast cancer non-profit funding breast care nurses rather than direct clinical trials. Comparable as an Australian breast cancer charity sharing donor base, but focused on patient care services rather than research.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks5 records
Key highlights7 records
Customer concentration
Breast Cancer Trials social profiles
Digital presenceBreast Cancer Trials compliance and trust
Trust signalCompliance4 records
Breast Cancer Trials financial estimates
Financial estimateRevenue estimate
Valuation estimate
Breast Cancer Trials leadership team
Management profileNumber of profiles
Profiles2 records
Breast Cancer Trials funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Breast Cancer Trials M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Breast Cancer Trials
What does Breast Cancer Trials do?
Breast Cancer Trials designs, coordinates, and conducts a multi-centre national and international clinical trials research program for breast cancer treatment, prevention, and cure, encompassing approximately 95 clinical trials across recruitment, follow-up, analysis, and publication stages. The program is delivered through 119 institutions in Australia and New Zealand and 68 international sites, supported by translational research via the BCT Biobank, a Remote Telehealth Pre-Screening service for rural and regional patients, a Clinical Fellowship Program for emerging researchers, and patient-facing decision-support tools (iPrevent and the Neoadjuvant Patient Decision Aid).
Is Breast Cancer Trials a public or private company?
Breast Cancer Trials is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Breast Cancer Trials founded?
Breast Cancer Trials was founded in 1978. It employs 11 to 50 people.
Where is Breast Cancer Trials based?
Breast Cancer Trials is headquartered in Newcastle, Australia, in the Oceania region.
How does Breast Cancer Trials make money?
Six revenue lines are on record. Individual Donations are the primary driver. The others are fundraising Events, gifts in Wills, merchandise Sales, corporate Partnerships and workplace Giving.
Who are Breast Cancer Trials's main competitors?
Broad incumbents on record are Susan G. Komen, Cancer Research UK and Cancer Council Australia. Direct peers are International Breast Cancer Study Group (IBCSG), Alliance for Clinical Trials in Oncology, Breast International Group (BIG), ECOG-ACRIN Cancer Research Group, National Breast Cancer Foundation (Australia) and NRG Oncology. McGrath Foundation is listed as a regional player.
Does Breast Cancer Trials have an API?
No public API is recorded for Breast Cancer Trials.
What industry is Breast Cancer Trials in?
Breast Cancer Trials's product category is Oncology Clinical Trials Research. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAFAJAK, Gynecologic Oncology & Women’s Cancer Centers. Its NAICS code is 5417 and its SIC code is 8731.